Alpha and gamma interferons rapidly induce several early response genes in primary human diploid fibroblasts. The transcription rates of these genes are maximal after 1 h of interferon treatment and return to basal levels within 8 h. Three different interferon-activated DNA-binding complexes (ISGF3, GAF, and FcRF-y) that are responsible for transcriptional activation of cellular genes have been characterized. Assembly of these complexes requires tyrosine phosphorylation of one or more of the protein components. In this report, we demonstrate that a nuclear tyrosine phosphatase is responsible for the deactivation of these interferonregulated transcription factors and the subsequent transcriptional downregulation of the corresponding genes. Furthermore, tyrosine phosphorylation is required for nuclear localization of the 91-kDa protein that is part of all three interferon-induced transcription complexes. These results provide the first evidence for a nuclear tyrosine phosphatase activity as a mechanism of transcriptional regulation.
tyrosine phosphatase activity as a mechanism of transcriptional regulation.
The rapid transcriptional activation of cellular genes by either alpha interferon (IFN-a) or IFN--y is responsible for many of the pleotropic actions of these cytokines. IFNactivated gene expression is mediated by the formation of protein complexes whose preexisting components assemble as a result of ligand-induced tyrosine phosphorylation. These complexes then translocate to the nucleus, where they bind to enhancers within IFN-activated genes (3, 5, 7, 12, 15, 18, 28) . Although the signals required for IFN induction of gene expression are becoming better understood, considerably less is known regarding how transcription of these genes becomes downregulated. In primary diploid fibroblasts, 6 to 8 h of continuous treatment with either IFN-a or IFN--y shuts off the transcription of early response genes and desensitizes cells such that reexposure to the cytokine is ineffective in reinducing the expression of IFN-stimulated genes (ISGs) (16) . As downregulation of ISGs in fibroblasts can be abrogated by inhibitors of protein synthesis, IFN- induced proteins were thought to be responsible for shutting off the transcriptional response (6, 9, 17) . A likely candidate to mediate this downmodulation would be a nuclear tyrosine phosphatase, because tyrosine phosphorylation is required for the integrity of the IFN-activated complexes ISG factor 3 (ISGF3), IFN--y-activated factor (GAF), and FcRI-binding factor, IFN--y induced (FcRFy) (4, 5, 10, 14, 15) . We therefore initiated experiments to explore whether dephosphorylation of IFN-induced transcription factors correlated with their nuclear localization and a decline in the rates of transcription of ISGs.
MATERIALS AND METHODS
Cells and culture. Human foreskin diploid fibroblasts (GM00468) from the National Institute of General Medical Science were grown and passaged in Dulbecco's modified Eagle's medium with 10% fetal bovine serum.
IFNs and reagents. Recombinant human IFN-a was a * Corresponding author.
generous gift from Hoffmann LaRoche. Recombinant human IFN--y was provided by Genentech Corp. Preparation of nuclear cell extracts. Cells were collected after being washed with phosphate-buffered saline and homogenized by a douncing in buffer A (20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES; pH 7.0], 10 mM KCl, 10 mM MgCl2, 1 mM orthovanadate, 0.5 mM dithiothreitol (DTT), 0.25 mM phenylmethylsulfonyl fluoride, 20% glycerol, 0.1% Nonidet P-40). The lysate was layered on a sucrose cushion (35% sucrose in 100 mM HEPES [pH 7.01-20 mM MgCl2), and the nuclei were isolated by centrifugation at 3,000 x g for 15 min. Nuclei were resuspended in buffer A with 0.3 M NaCl and extracted by vortexing.
Selected extracts were treated with 10 mM N-ethylmaleimide (NEM) for 20 min at room temperature and then quenched with 20 mM DTT on ice for 10 min.
Antibodies. ISGF3 is composed of three ISGF3ao proteins (p84, p91, and p113) and a 48-kDa DNA-binding component, ISGF3-y (11, 18) . Antibodies specific for p91 were raised against a peptide corresponding to the C-terminal 39-aminoacid region that is not present in the splicing variant p84. Antibodies directed against the amino acids 607 to 647 of p91 and p84 recognized both proteins. A (3, 7, 18, 32) . Because assembly of ISGF3, GAF, and FcRF-y requires tyrosine phosphorylation (5, 10, 14, 15, 29) , a nuclear phosphotyrosine phosphatase (PTP) might be responsible for the observed decrease in the concentration of these transcription complexes with prolonged IFN treatment. Therefore, we investigated whether the tyrosine phosphatase inhibitor orthovanadate could prevent the inactivation of these transcription complexes. Incubation of fibroblasts with IFN-a (500 U/ml) for 1 h activated formation of GAF ( with IFN-at (data not shown). When 1 mM orthovanadate was added after 1 h of IFN-a and was subsequently present for 7 more h, the integrity of all three transcription complexes (lanes 5, 10, and 15) was preserved. Vanadate was added 1 h after IFN-a because a membrane-associated PTP is also required for the activation of the complex (5, 14) . The serine/threonine phosphatase inhibitors okadaic acid and calyculin A were ineffective in preserving the integrity of the transcription factors (data not shown). Although the protein synthesis inhibitor cycloheximide (30 pg/ml) is known to prevent downregulation of IFN-induced transcription (7, 16) , it had only a small effect on maintaining the assembly of GAF, FcRF-y, and ISGF3 (lanes 4, 9, and 14) during incubation with IEN. To exclude the possibility that the short half-life of ISGF3-y (the DNA-binding component of ISGF3) was responsible for the disappearance of ISGF3 in these experiments, we used a reconstitution assay with in vitrotranslated ISGF3y (30) (5, 12, 28) . To determine whether the ISGF3 observed after 8 h of IFN-a-plus-vanadate treatment contained the same proteins as in ISGF3 seen after 1 h of IFN-ax treatment of cells, extracts were prepared and incubated with specific antibodies against p91, p113, and ISGF3-y. All three antibodies formed supershifted complexes with ISGF3 from the short (Fig. 1B , lanes 2 to 5) and prolonged (lanes 7 to 10) treatment. Anti-p91 antibody also supershifted the GAF and FcRF-y complexes, which do not contain p113 or ISGF3-y, in extracts prepared from cells incubated with vanadate and IFN-ac for 8 h (data not shown).
Vanadate prevents transcriptional downregulation of IFNa-induced genes. To evaluate whether a direct correlation existed between the presence of the transcription complexes maintained by vanadate and elevated transcription rates of IFN-a-induced genes, we performed nuclear run-on assays (Fig. 2 ). Cells were treated as described in the legend to Fig.  1 , and the nuclei were isolated and incubated in the presence of [aL-32P]UTP. 32P-labeled RNA was isolated and hybridized to cDNA probes corresponding to the IFN-a-stimulated genes ISG54, ISG15, and FcRI and the GBP. After hybridization and autoradiography, transcription rates were quantitated by direct counting. As in previously published results (6, 17, 25) , IFN-a treatment of cells for 1 h induced high rates of transcription of ISG15, ISG54, and GBP, which in the continuous presence of the cytokine for 8 h declined to nearly undetectable levels. Addition of cycloheximide 30 min prior to incubation with IFN-a maintained elevated transcription rates, whereas vanadate-treated cells exceeded maximal levels of transcription observed after 1 h of IFN-a treatment (Fig. 2) . Since IFN induction of the FcRI transcription is restricted to cells of myeloid lineage, no transcription of the gene was detected in spite of FcRF-y formation (32) . These data confirm that a complete correlation exists between the ability of vanadate to maintain IFN-ainduced levels of ISGF3 or GAF and the rates of transcription of their corresponding genes. However, no such correlation was noted with cycloheximide, which was able to maintain elevated transcription rates but only marginally preserved the assembly of the transcription complexes (compare Fig. 1, lanes 4 and 14, with Fig. 2 ).
Tyrosine phosphorylation of p91 parallels assembly of transcription factors and transcription rates. Because tyrosinephosphorylated p91 is the common component found in IFN-a-activated ISGF3 as well as in IFN-a-and IFN--yactivated GAF and FcRFy (1, 15, 22, 23, 29) , experiments MOL. CELL. BIOL. Fig. 1 . Nuclear run-on assays were performed, and labeled RNA was hybridized to Nytran filters containing the indicated cDNA clones. After hybridization, the filters were subjected to autoradiography. ISG54, 54-kDa ISG; ISG15, 15-kDa ISG; FcRI, high-affinity immunoglobulin G FcRI gene; Actin, chicken P-actin; Vector, pGEM; GBP, guanylate-binding protein. were initiated to characterize the fate of tyrosine-phosphorylated p91 as a result of extended treatment of cells with IFN-a or IFN--y. Human fibroblasts were treated with either IFN for 1 or 8 h or for 8 h in the presence of vanadate or cycloheximide. After lysis, nuclei were isolated by sucrose density centrifugation and extracted, and the extracts were immunoprecipitated with an antibody against the p91 protein. The immunoprecipitates were resolved on SDS-polyacrylamide gels, blotted, and probed with anti-phosphotyrosine antibodies. Treatment of cells for 1 h with either IFN-a or IFN--y resulted in tyrosine-phosphorylated p91 (Fig. 3A, lanes 1 and 6 versus 2 and 7) , and in agreement with the gel shift experiments, further incubation for 7 more h led to the complete loss of tyrosine phosphorylation of p91 (lanes 3 and 8) . Incubation of cells with either IFN-ca or IFN--y for 8 h in the presence of vanadate maintained p91 as a tyrosine-phosphorylated species in the nuclei (lanes 5 and 10), while cycloheximide had very little effect (lanes 4 and 9) . These results not only confirmed the data from the gel shift and nuclear run-on experiments, but they also reinforced the Phosphotyrosine blots of immunoprecipitated p91. Fibroblasts were exposed to either IFN-a (500 U/ml) or IFN--y (5 ng/ml), and nuclei were isolated and extracted under the conditions described in the legend to Fig. 1 . Extracts were incubated with the antiserum against p91 for 16 h at 40C, and the resulting immunoprecipitates were resolved on 8% polyacrylamide-SDS gels. The gels were transferred to Immobilon and probed with an anti-phosphotyrosine antibody. The phosphotyrosine blots revealed that no tyrosinephosphorylated p91 was present in the nuclei of either untreated cells or cells exposed to IFNs for 8 h. To determine whether p91 was present in the unphosphorylated form in the nucleus, the same blots initially probed with antiphosphotyrosine antibodies were reprobed with anti-p91 antibodies. As shown in Fig. 3B , p91 was only present in the nuclei of those samples shown to be tyrosine phosphorylated in Fig. 3A (compare lanes 2, 5, 7 , and 10 of Fig. 3A and B) . DISCUSSION Homeostasis requires downregulation of many cellular responses resulting from extended exposure to external stimuli such as cytokines, growth factors, and hormones. Initial studies indicated that a protein synthesis-dependent mechanism functioned to shut off IFN-activated transcription of early response genes (9, 16) . However, recent reports, which have shown that IFN-a-and IFN--y-induced formation of several transcription complexes (ISGF3, GAF, and FcRF-y) required tyrosine phosphorylation (5, 10, 12, 14, 15, 22, 23, 28, 29) suggested that a nuclear tyrosine phosphatase might be one mechanism to downregulate IFNinduced gene expression. Although no evidence has so far been presented for the role of nuclear PTPs in regulation of gene expression, it has been reported that type 1 or 2A serine/threonine phosphatases downregulate the cyclic AMP-responsive transcription factor CREB after forskolin induction (13, 31) . In this report we describe a nuclear PTP activity that is able to dephosphorylate IFN-activated transcription factors and to turn off the transcription of ISGs.
Exposure of IFN-stimulated cells to the PTP inhibitor vanadate prevented the downmodulation of the transcription complexes observed during extended incubation. Furthermore, nuclear run-on experiments demonstrated that the transcription rates of several lEN-a-induced genes remained elevated for 8 h in the presence the cytokine and vanadate ( Fig. 1 and 2) . To characterize what role tyrosine phosphorylation contributed to maintenance of elevated transcription rates, fibroblast nuclear extracts were immunoprecipitated by using an antibody against p91, the common component of ISGF3, GAF, and FcRF-y. The results of these experiments demonstrated that incubation with either IFN-a or IFN-^y and vanadate maintained p91 in its tyrosine-phosphorylated state within the nucleus and that the presence of nuclear, tyrosine-phosphorylated p91 correlated with elevated rates of transcription. These data clearly support the role of a nuclear PTP as a transcriptional downregulator of ISGs.
Interestingly, none of the conditions used in these experiments permitted detection of unphosphorylated (tyrosine) p91 in the nuclei. This finding implied that tyrosine phosphorylation is needed not only for assembly of the transcription complexes but also for targeting the proteins to the nucleus and maintaining their nuclear localization. At the moment it is not evident whether dephosphorylated p91 is degraded in the nucleus or is recycled to the cytoplasm to be reactivated. Although we assume that p84 and p113 are processed in a manner similar to that for p91, the antibodies presently available do not immunoprecipitate these proteins efficiently enough to perform these studies.
Those few nuclear-localized PTPs which have thus far been purified are very substrate specific (8, 20, 26) , and their activity does not appear to be regulated by treatment of cells with cytokines or growth factors. The nuclear PTP(s) activity which dephosphorylates the IFN-induced transcription complexes described in this work also appears to be constitutively expressed. This conclusion is suggested by the fact that preincubation with cycloheximide did not substantially maintain IFN-induced ISGF3, GAF, or FcRF-y formation or retain tyrosine-phosphorylated p91 in the nucleus. 
